Showing 2161-2170 of 4367 results for "".
Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/21961/Dermatology Q&A: First Head-to-Head Data Highlight Safety and Efficacy of Biologics
https://practicaldermatology.com/topics/psoriasis/first-head-to-head-data-highlight-safety-and-efficacy-of-biologics/22032/A lead investigator on the first head-to-head trial of biologics shares insights on the future of biologic research and therapy.A Survey of Snow Sports Participants’ Attitudes and Beliefs About Sun Safety
https://practicaldermatology.com/youngmd-connect/resident-resource-center/a-survey-of-snow-sports-participants-attitudes-and-beliefs-about-sun-safety/23134/An atypical presentation of unilateral, linear, hypertrophic lichen planus in a Patient with HIV
https://practicaldermatology.com/youngmd-connect/resident-resource-center/an-atypical-presentation-of-unilateral-linear-hypertrophic-lichen-planus-in-a-patient-with-hiv/20875/Letter to the Editor
https://practicaldermatology.com/columns/letter-to-the-editor/letter-to-the-editor-2/23905/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-28/23605/Therapeutics Update
https://practicaldermatology.com/topics/psoriasis/therapeutics-update/20530/New products and pharmacologic developmentsPipeline and Potential Roles for GLP-1RAs in Dermatology
https://practicaldermatology.com/issues/novemberdecember-2025/pipeline-and-potential-roles-for-glp-1ras-in-dermatology/48898/Having reviewed the mechanism of action and current roles in medicine for glucagon-like peptide 1 receptor agonists (GLP-1RAs), we now can discuss therapies in this class currently under investigation for management of dermatologic disease.Closing Gaps in Care for People of Color with Psoriatic Disease
https://practicaldermatology.com/programs/practical-dermatology/closing-gaps-in-care-for-people-of-color-with-psoriatic-disease/18190/Black, Hispanic, Asian, and other people of color with plaque psoriasis and psoriatic arthritis often face delayed diagnosis, misdiagnosis, and limited access to testing, treatment, and care. Determi-Nation, a new initiative sponsored by Janssen Pharmaceuticals, aims to change this. Patient advocateFrax Pro and CoolSculpting Elite Launch, Antibiotic Resistance in Rosacea, Thriving in Aesthetics Rolls Out
https://practicaldermatology.com/series/dermwire-tv/frax-pro-and-coolsculpting-elite-launch-antibiotic-resistance-in-rosacea-thriving-in-aesthetics-rolls-out/19896/The majority of rosacea patients have never heard of antibiotic resistance, a new survey reported by the National Rosacea Society finds. Candela’s Frax Pro system is now available, featuring Frax 1550 and the novel Frax 1940 applicators. Allergan Aesthetics, an AbbVie company, is launching CoolSculp